Up next

Autoplay

Minimal Residual Disease in Acute Lymphoblastic Leukemia

1 Views • 06/15/23
Share
Embed
administrator
administrator
Subscribers
0

The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay